Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
Public ClinicalTrials.gov record NCT02012218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Open-label Exploratory Trial to Evaluate the Efficacy, Safety, and Subject Satisfaction With Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this exploratory trial are to evaluate the efficacy, safety, and subjects' subjective satisfaction when switching to adjunctive brexpiprazole in subjects with MDD who have responded inadequately to preceding adjunctive drug therapy.
Study identification
- NCT ID
- NCT02012218
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2013 (Type not available)
- Primary completion
- Oct 2014 (Actual)
- Completion
- Oct 2014 (Actual)
- Last update posted
- Dec 29, 2015
2013 – 2014
United States locations
- U.S. sites
- 24
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative NeuroScience Network, Inc. | Garden Grove | California | 92845 | — |
| Viking Clinical Research, Ltd. | Temecula | California | 92591 | — |
| Clinical Neuroscience Solutions Pharmacology | Orlando | Florida | 32806 | — |
| Carman Research | Smyrna | Georgia | 30080 | — |
| Goldpoint Clinical Research | Indianapolis | Indiana | 46260 | — |
| Alpine Clinic | Lafayette | Indiana | 47905 | — |
| Pharmasite Research | Baltimore | Maryland | 21208 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Coastal Research Associates, Inc. | Weymouth | Massachusetts | 02190 | — |
| Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63118 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| Behavioral Medical Research of Staten Island | Staten Island | New York | 10305 | — |
| Richard H. Weisler, MD, PA | Raleigh | North Carolina | 27609 | — |
| Midwest Clinical Research Center MCRC | Dayton | Ohio | 45417-3445 | — |
| Cutting Edge Research Group | Oklahoma City | Oklahoma | 73116 | — |
| Oregon Center for Clinical Investigations, Inc. | Portland | Oregon | 97210 | — |
| Oregon Center for Clinical Investigations, Inc. | Salem | Oregon | 97301 | — |
| Lehigh Center for Clinical Research | Allentown | Pennsylvania | 18104 | — |
| Lincoln Research, LLC | Lincoln | Rhode Island | 02865 | — |
| Research Strategies of Memphis, LLC | Memphis | Tennessee | 38119 | — |
| Future Search Trials of Dallas, LP | Dallas | Texas | 75231 | — |
| NeuropsychiatricAssociates | Woodstock | Vermont | 05091 | — |
| Frontier Institute | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02012218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 29, 2015 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02012218 live on ClinicalTrials.gov.